Regeneron gets federal approval for new eczema drug Robin LaBrake|March 29, 2017 Regeneron Pharmaceuticals won federal approval for new drug which could lead to more than $3 billion in annual sales. Click here to read the story from the Albany Business Review Previous PostGroundbreaking Ceremony held for Best Western Franklin Square Inn TroyNext PostSEED Program Accepting Applications for Spring Session
